Literature DB >> 1775855

Seroepidemiology of pertussis in Italy.

A Giammanco1, A Chiarini, T Stroffolini, D De Mattia, M Chiaramonte, M E Moschen, I Mura, G Rigo, S Taormina, A Sarzana.   

Abstract

During 1988 and 1989 the prevalence of serum IgG antibodies to pertussis toxin in a sample of 3,875 unvaccinated, apparently healthy persons between the ages of 1 year to 19 years was estimated by enzyme-linked immunosorbent assay. The participants were recruited by means of systematic cluster sampling from public and private schools in five geographic areas of Italy. The overall prevalence of IgG antibodies was 80.8%, with a steady increase from 33.5% among 1- to 3-year-old children to 95% among 17- to 19-year-old individuals. The prevalence of natural immunity was 50% and 75% at the ages of 4 and 6 years, respectively. No gender-related difference in immunity was observed. For children greater than 10 years of age, the seroprevalence of pertussis antibodies was significantly higher in northern regions than in southern regions until the age of 17-19 years, when the pattern reversed. There was no association of a child's immune status with the father's number of years of schooling or with family size. For children aged 1-3 years, serologic studies showed that the history of pertussis reported by parents in questionnaires was highly specific (97.6%) in predicting antibody status, with positive and negative predictive values of 90.5% and 79.2%, respectively. However, 20.8% of children had antibodies to pertussis toxin even though they had no history of whooping cough.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775855     DOI: 10.1093/clinids/13.6.1216

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  11 in total

1.  Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.

Authors:  H E de Melker; F G Versteegh; M A Conyn-Van Spaendonck; L H Elvers; G A Berbers; A van Der Zee; J F Schellekens
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.

Authors:  A Polyzou; S Pournaras; U Dafni; D Sofianou; E Christeli; S Patrinos; A Tsakris
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

3.  Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy.

Authors:  G Gabutti; M Bergamini; P Bonanni; M Guido; D Fenoglio; A Giammanco; L Sindoni; C Zotti; V Boddi; F Bamfi; R Severini; A Bechini; S Boccalini; P Crovari
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

Review 4.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  The seroepidemiology of pertussis in Australia during an epidemic period.

Authors:  M Cagney; C R MacIntyre; P McIntyre; M Puech; A Giammanco
Journal:  Epidemiol Infect       Date:  2006-05-11       Impact factor: 2.451

6.  Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis.

Authors:  K Kösters; M Riffelmann; B Dohrn; C H von König
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.

Authors:  Maja Socan; Katarina Prosenc; Miljana Vegnuti
Journal:  Wien Klin Wochenschr       Date:  2006-06       Impact factor: 1.704

8.  Factors influencing the spread of pertussis in households.

Authors:  C H Wirsing von König; S Postels-Multani; H Bogaerts; H L Bock; S Laukamp; S Kiederle; H J Schmitt
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

9.  Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.

Authors:  C A Guzman; G Molinari; M W Fountain; M Rohde; K N Timmis; M J Walker
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

10.  Seroprevalence of Bordetella pertussis in the Mexican population: a cross-sectional study.

Authors:  C Conde-Glez; E Lazcano-Ponce; R Rojas; R DeAntonio; L Romano-Mazzotti; Y Cervantes; E Ortega-Barría
Journal:  Epidemiol Infect       Date:  2013-06-05       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.